Unassociated Document
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of report (Date of earliest event reported): November 18, 2009
CHINA
JO-JO DRUGSTORES, INC.
(Exact
name of registrant as specified in Charter)
|
Nevada
|
|
333-147698
|
|
98-0557852
|
|
(State
or other jurisdiction of
incorporation
or organization)
|
|
(Commission
File No.)
|
|
(IRS
Employee Identification
No.)
|
Room
507-513, 5th Floor A Building, Meidu Plaza
Gongshu
District, Hangzhou, Zhejiang Province
People’s
Republic of China
(Address
of Principal Executive Offices)
+86
(571) 88077078
(Registrant’s
Telephone number)
N/A
(Former name or
former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material
pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR
240.14a-12(b))
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Forward
Looking Statements
This Form
8-K and other reports filed by China Jo-Jo Drugstores, Inc. (the “Registrant”)
from time to time with the Securities and Exchange Commission (collectively the
“Filings”) contain forward looking statements and information that are based
upon beliefs of, and information currently available to, the Registrant’s
management as well as estimates and assumptions made by the Registrant’s
management. When used in the Filings the words “anticipate”,
“believe”, “estimate”, “expect”, “future”, “intend”, “plan” or the negative of
these terms and similar expressions as they relate to the Registrant or the
Registrant’s management identify forward looking statements. Such
statements reflect the current view of the Registrant with respect to future
events and are subject to risks, uncertainties, assumptions and other factors
relating to the Registrant’s industry, operations and results of operations and
any businesses that may be acquired by the Registrant. Should one or
more of these risks or uncertainties materialize, or should the underlying
assumptions prove incorrect, actual results may differ significantly from those
anticipated, believed, estimated, expected, intended or planned.
Although
Registrant believes that the expectations reflected in the forward looking
statements are reasonable, Registrant cannot guarantee future results, levels of
activity, performance or achievements. Except as required by applicable law,
including the securities laws of the United States, Registrant does not intend
to update any of the forward-looking statements to conform these statements to
actual results.
In this
Form 8-K, references to “we,” “our,” “us,” “Company,” “Skystar” or the
“Registrant” refer to Skystar Bio-pharmaceutical Company, a Nevada
corporation.
Item
7.01 Regulation FD Disclosure
The
presentation materials attached hereto as Exhibit 99.1 are being filed in
connection with potential investor presentations by the Registrant.
The
information in this current report, including the presentation attached hereto
as Exhibit 99.1, is being furnished pursuant to Item 7.01 and shall not be
deemed "filed" for the purposes of Section 18 of the Securities and Exchange Act
of 1934, as amended, or otherwise subject to the liabilities of that Section.
The information in the Current Report shall not be incorporated by reference
into any registration statement pursuant to the Securities Act of 1933, as
amended.
Item 9.01 Financial Statement and
Exhibits.
|
Exhibit
Number
|
|
Description
|
|
|
|
|
|
16.1
|
|
Presentation
materials dated November 18,
2009
|
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the Registrant has duly caused this Report to
be signed on its behalf by the undersigned hereunto duly
authorized.
|
|
|
|
|
Date:
November 18, 2009
|
China
Jo-Jo Drugstores, Inc.
(Registrant)
|
|
|
|
|
|
|
By:
|
/s/
Lei Liu
|
|
|
Lei
Liu
|
|
|
Chief
Executive Officer
|